Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The 100 Most-Cited Papers on Giant Cell Arteritis: A Bibliometric Analysis

Author(s): Jim S. Xie and Jonathan A. Micieli*

Volume 19, Issue 2, 2023

Published on: 30 June, 2022

Page: [122 - 133] Pages: 12

DOI: 10.2174/1573397118666220527143435

Price: $65

Abstract

Background: Giant cell arteritis (GCA) carries a significant risk of vascular and visual morbidity. Given its clinical importance, the 100 most frequently cited articles on GCA were systematically identified and bibliometrically analyzed.

Methods: All databases belonging to the Web of Science platform were searched for research articles with no restriction on publication date. The distribution of papers among journals, countries of origin, and publication types were evaluated. The correlations between the year of publication with total number of citations and annual citation rate were also assessed.

Results: The top 100 articles on GCA were published between 1946 and 2018 and were cited a median (range) of 229 (153-1751) times. The papers were published in 30 journals, including nine rheumatology journals (n= 45), seven general medical journals (n= 21), three ophthalmology journals (n= 8), and eleven journals from other fields of research (n= 26). Based on corresponding author affiliation, the articles originated from 13 countries, led by the US (n= 55), Spain (n= 12), and the UK (n= 11). Clinical studies (n= 73) and non-systematic reviews (n= 11) were the most common publication types. The median (range) number of authors per article was 5 (1-44), and 73 individuals had more than one authorship. Year of publication was significantly correlated with the annual citation rate (P<0.001) but not with the total number of citations (P= 0.487).

Conclusion: This bibliometric analysis provides insight into the history and evolution of GCA research, highlighting some of the most influential contributions to the field. The latest landmark papers may not have been identified due to temporal constraints on citation accumulation.

Keywords: Giant cell arteritis, temporal arteritis, cranial arteritis, bibliometrics, citations, publications.

« Previous Next »
Graphical Abstract

[1]
Hutchinson J. Diseases of the arteries. Arch Surg 1890; 1: 323-33.
[2]
Horton BT. An undescribed form of arteritis of temporal vessels. Proc Staff Meet Mayo Clin 1932; 7: 700-1.
[3]
Gilmour JR. Giant-cell chronic arteritis. J Pathol Bacteriol 1941; 53: 263-77.
[http://dx.doi.org/10.1002/path.1700530210]
[4]
Kilbourne ED, Wolff HG. Cranial arteritis; a critical evaluation of the syndrome of temporal arteritis with report of a case. Ann Intern Med 1946; 24: 1-10.
[http://dx.doi.org/10.7326/0003-4819-24-1-1] [PMID: 21009780]
[5]
Andersen T. Arteritis temporalis (Horton) (a symptom of a generalized vascular disease) a survey and a case with glaucoma. Acta Med Scand 1947; 128(2): 151-78.
[http://dx.doi.org/10.1111/j.0954-6820.1947.tb06591.x] [PMID: 18897394]
[6]
McMILLAN GC. Diffuse granulomatous aortitis with giant cells associated with partial rupture and dissection of the aorta. AMA Arch Pathol 1950; 49(1): 63-9.
[PMID: 15399231]
[7]
Olhagen B. Polymyalgia rheumatica. A form of senile arteritis? Acta Rheumatol Scand 1963; 9: 157-64.
[http://dx.doi.org/10.3109/rhe1.1963.9.issue-1-4.20] [PMID: 14042488]
[8]
Hamrin B, Jonsson N, Landberg T. Arteritis in “polymyalgia rheumatica.”. Lancet 1964; 1(7330): 397-401.
[http://dx.doi.org/10.1016/S0140-6736(64)92784-9] [PMID: 14092952]
[9]
Putman MS, Gribbons KB, Ponte C, et al. Clinicopathologic associations in a large international cohort of patients with giant cell arteritis. Arthritis Care Res (Hoboken) 2020.
[http://dx.doi.org/10.1002/acr.24540] [PMID: 33338326]
[10]
Horton BT, Magath TB. Arteritis of the temporal vessels: Report of seven cases. Staff Meeting Mayo Clinic 1937; 12: 548-53.
[11]
Sproul EE, Hawthorne JJ. Chronic diffuse mesaortitis: Report of two cases of unusual type. Am J Pathol 1937; 13: 311-323.4.
[12]
Jennings GH. Arteritis of the temporal vessels. Lancet 1938; 231: 424.
[http://dx.doi.org/10.1016/S0140-6736(00)86182-6]
[13]
Dick GF, Freeman G. Temporal arteritis. JAMA 1940; 114: 645-7.
[http://dx.doi.org/10.1001/jama.1940.02810080017005]
[14]
Cooke WT, Cloake PCP, et al. Temporal arteritis; a generalized vascular disease. Q J Med 1946; 15: 47-75.
[http://dx.doi.org/10.1093/qjmed/15.57.47] [PMID: 21019546]
[15]
Magarey FR. Dissecting aneurysm due to giant-cell aortitis. J Pathol Bacteriol 1950; 62(3): 445-6.
[http://dx.doi.org/10.1002/path.1700620318] [PMID: 14784910]
[16]
Cardell BS, Hanley T. A fatal case of giant-cell or temporal arteritis. J Pathol Bacteriol 1951; 63(4): 587-97.
[http://dx.doi.org/10.1002/path.1700630405] [PMID: 14898364]
[17]
Wagener HP, Hollenhorst RW. The ocular lesions of temporal arteritis. Am J Ophthalmol 1958; 45(5): 617-30.
[http://dx.doi.org/10.1016/0002-9394(58)92165-2] [PMID: 13533472]
[18]
Ross Russell RW. Giant-cell arteritis. QJM 1959; 28: 471-89.
[http://dx.doi.org/10.1093/oxfordjournals.qjmed.a066853]
[19]
Boes CJ. Bayard Horton’s clinicopathological description of giant cell (temporal) arteritis. Cephalalgia 2007; 27(1): 68-75.
[http://dx.doi.org/10.1111/j.1468-2982.2007.01238.x] [PMID: 17212686]
[20]
Birkhead NC, Wagener HP, Shick RM. Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy. J Am Med Assoc 1957; 163(10): 821-7.
[http://dx.doi.org/10.1001/jama.1957.02970450023007] [PMID: 13405740]
[21]
Ma-Krupa W, Jeon M-S, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004; 199(2): 173-83.
[http://dx.doi.org/10.1084/jem.20030850] [PMID: 14734523]
[22]
Weyand CM, Liao YJ, Goronzy JJ. The immunopathology of giant cell arteritis: Diagnostic and therapeutic implications. J Neuroophthalmol 2012; 32(3): 259-65.
[http://dx.doi.org/10.1097/WNO.0b013e318268aa9b] [PMID: 22914691]
[23]
Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med 2017; 377(4): 317-28.
[http://dx.doi.org/10.1056/NEJMoa1613849] [PMID: 28745999]
[24]
Yin X, Cheng F, Wang X, et al. Top 100 cited articles on rheumatoid arthritis: A bibliometric analysis. Medicine (Baltimore) 2019; 98(8): e14523.
[http://dx.doi.org/10.1097/MD.0000000000014523] [PMID: 30813156]
[25]
Berlinberg A, Bilal J, Riaz IB, Kurtzman DJB. The 100 top-cited publications in psoriatic arthritis: A bibliometric analysis. Int J Dermatol 2019; 58(9): 1023-34.
[http://dx.doi.org/10.1111/ijd.14261] [PMID: 30315571]
[26]
Perez-Cabezas V, Ruiz-Molinero C, Carmona-Barrientos I, et al. Highly cited papers in rheumatology: Identification and conceptual analysis. Scientometrics 2018; 116: 555-68.
[http://dx.doi.org/10.1007/s11192-018-2712-z]
[27]
Kwan YH, Chua CJ, Kian JXL, Fong W. Top 100 cited articles in the field of rheumatology. Eur J Rheumatol 2017; 4(4): 294-304.
[http://dx.doi.org/10.5152/eurjrheum.2017.17027] [PMID: 29308289]
[28]
Campbell FM. National bias: A comparison of citation practices by health professionals. Bull Med Libr Assoc 1990; 78(4): 376-82.
[PMID: 2224301]
[29]
Link AM. US and non-US submissions: An analysis of reviewer bias. JAMA 1998; 280(3): 246-7.
[http://dx.doi.org/10.1001/jama.280.3.246] [PMID: 9676670]
[30]
Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998; 125(4): 509-20.
[http://dx.doi.org/10.1016/S0002-9394(99)80192-5] [PMID: 9559737]
[31]
Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology 1993; 100(4): 550-5.
[http://dx.doi.org/10.1016/S0161-6420(93)31608-8] [PMID: 8479714]
[32]
Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: Validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997; 123(3): 285-96.
[http://dx.doi.org/10.1016/S0002-9394(14)70123-0] [PMID: 9063237]
[33]
Krauthammer M, Moisseiev E. The 100 most cited articles on vitrectomy: A bibliographic perspective. Ophthalmol Retina 2020; 4(4): 361-8.
[http://dx.doi.org/10.1016/j.oret.2019.10.016] [PMID: 31956076]
[34]
Grzybowski A, Shtayer C, Schwartz SG, Moisseiev E. The 100 most cited papers on retinal detachment: A bibliographic perspective. Br J Ophthalmol 2022; 106(3): 305-11.
[http://dx.doi.org/10.1136/bjophthalmol-2020-318015] [PMID: 33785506]
[35]
Garfield E. 100 citation classics from the Journal of the American Medical Association. JAMA 1987; 257(1): 52-9.
[http://dx.doi.org/10.1001/jama.1987.03390010056028] [PMID: 3537352]
[36]
Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347(4): 261-71.
[http://dx.doi.org/10.1056/NEJMra011913] [PMID: 12140303]
[37]
Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003; 349(2): 160-9.
[http://dx.doi.org/10.1056/NEJMra022694] [PMID: 12853590]
[38]
Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33(8): 1122-8.
[http://dx.doi.org/10.1002/art.1780330810] [PMID: 2202311]
[39]
Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978; 88(2): 162-7.
[http://dx.doi.org/10.7326/0003-4819-88-2-162] [PMID: 626444]
[40]
Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975; 83(6): 806-12.
[http://dx.doi.org/10.7326/0003-4819-83-6-806] [PMID: 1200525]
[41]
Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018; 77(5): 636-43.
[http://dx.doi.org/10.1136/annrheumdis-2017-212649] [PMID: 29358285]
[42]
Villiger PM, Adler S, Kuchen S, et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: A phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2016; 387(10031): 1921-7.
[http://dx.doi.org/10.1016/S0140-6736(16)00560-2] [PMID: 26952547]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy